AzioInositols in the Treatment of Insulin-Mediated Diseases
A growing body of research is currently focused on the role of inositol isomers and in particular myo-inositol (MYO-INS) and D-chiroinositol (DCI) in the treatment of insulin resistance states. Both isomers have been shown to exert insulin-mimetic action and to lower postprandial glucose. Further, i...
Saved in:
Main Authors: | Giovanna Muscogiuri, Stefano Palomba, Antonio Simone Laganà, Francesco Orio |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2016/3058393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erratum to “Inositols in the Treatment of Insulin-Mediated Diseases”
by: Giovanna Muscogiuri, et al.
Published: (2016-01-01) -
Inositols in Insulin Signaling and Glucose Metabolism
by: Arturo Bevilacqua, et al.
Published: (2018-01-01) -
The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
by: Basilio Pintaudi, et al.
Published: (2016-01-01) -
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
by: Elena Benelli, et al.
Published: (2016-01-01) -
Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01)